Last C$0.09 CAD
Change Today +0.02 / 28.57%
Volume 5.3M
EKG On Other Exchanges
Symbol
Exchange
Venture
OTC US
Stuttgart
As of 2:24 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

cardiocomm solutions inc (EKG) Snapshot

Open
C$0.07
Previous Close
C$0.07
Day High
C$0.10
Day Low
C$0.07
52 Week High
02/2/15 - C$0.14
52 Week Low
10/15/14 - C$0.03
Market Cap
10.0M
Average Volume 10 Days
328.0K
EPS TTM
C$-0.01
Shares Outstanding
110.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CARDIOCOMM SOLUTIONS INC (EKG)

Related News

No related news articles were found.

cardiocomm solutions inc (EKG) Related Businessweek News

No Related Businessweek News Found

cardiocomm solutions inc (EKG) Details

CardioComm Solutions, Inc. is engaged in the development of hardware and software for the cardiology field in the United States, Canada, and other countries. The company’s technology is used in various products for recording, viewing, analyzing, and storing electrocardiograms (ECGs) for the diagnosis and management of cardiac patients. Its software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 3 Lead; GlobalCardio 12 Lead, a Web enabled portable ECG device that is electronic medical records (EMR) compatible; and ECG Viewer SDK. The company also offers software modules, such as GEMS Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 and EMR Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; GlobalCardio EMR integration that integrates with EMR and enables bidirectional movement of data; and GEMS Lite, an electronic ECG receiving system. In addition, it provides hardware products comprising HeartCheck, a handheld ECG monitors; HeartCheck PEN; QRS Diagnostic; Cardiac Science Atria ECG recorders; DR200/HE, a holter and event recorder; Burdick Atria 3100 ECG, an electrocardiogram system for private practices; Burdick Atria 6100 ECG, a portable ECG/EKG system for hospitals and cardiology clinics; GEMSTrak AF, a cardiac event recorder with atrial fibrillation auto-capture; and ECG electrodes. Further, the company offers ASP services, including C4 ECG management services. It serves hospitals, call centers, and physician’s offices through a combination of the company’s external distribution network and sales team. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in North York, Canada.

Founded in 1989

cardiocomm solutions inc (EKG) Top Compensated Officers

Chief Executive Officer, Corporate Secretary,...
Total Annual Compensation: C$250.0K
Chief Financial Officer
Total Annual Compensation: C$30.0K
Compensation as of Fiscal Year 2013.

cardiocomm solutions inc (EKG) Key Developments

Cardiocomm Solutions, Inc. Enters into Three Year Renewable, Non-Exclusive, Co-Marketing and Distribution Agreement with Braemar Manufacturing

CardioComm Solutions Inc. announced it has entered into a three year renewable, non-exclusive, co-marketing and distribution agreement with Braemar Manufacturing Ltd. Under the agreement, the parties will collaborate to develop and execute on business opportunities in the GSM based wireless ECG event/arrhythmia monitoring market globally. CardioComm Solutions develops and distributes GEMSTM WIN and GEMSTM AIR ECG software management technologies for use in the ambulatory monitoring of patients, to independent diagnostic testing facilities, hospitals and clinic groups. Braemar engineers, manufactures and sells non-invasive, transtelephonic and GSM enabled wireless ECG recording and arrhythmia detection cardiac monitors. CardioComm Solutions expects to benefit from increased sales of its GEMSTM WIN software and from customers upgrading their license to include GEMSTM AIR. Additionally, CardioComm Solutions will be provided a per-device fee for sales that are derived though CardioComm Solutions sales leads.

Cardiocomm Solutions Inc. Enters into Sales and Marketing Agreement

CardioComm Solutions Inc. announced that it has entered into a sales and marketing agreement for growing and managing the Company’s HeartCheck™ ECG related business in drug chains, mass retailers, club retailers, grocery retailers and distributors’ head offices in the USA.

Cardiocomm Solutions Completes Software Development Agreement with the Release of GEMSTM 4.0

CardioComm Solutions Inc. announced it has completed the final milestone of a software and source code licensing agreement (SLA) for use of the Company's Global ECG Management Solution (GEMSTM) and GUAVA ECG viewer by MD Primer Inc. (MDP). The final milestone was achieved through the completion and release of the Company's GEMSTM 4.0 software. Pursuant to the SLA, completion of GEMSTM 4.0 has triggered a third and final $100,000 payment milestone by MD Primer. The GEMS 4.0 software released is designed for the ECG management of recordings collected and transmitted through the use of analogue devices which has market applicability in Canada and the USA. The Company has indicated that it will review further enhancements of GEMS 4.0 in 2015. Under the SLA, MDP is licensed to use the GEMSTM WIN, GEMSTM 4.0 and GUAVA software and the source code in support of MDP's current research-based business activities. MDP may not use the licensed materials to compete with CardioComm Solutions' business and CardioComm Solutions will not enter into another concurrent source-code based licensing agreement for the products named under the SLA. The third and final installment milestone payment is now confirmation that the Company's GEMSTM 4.0 software has been released commercially well in advance of the stated November 7, 2015 deadline. Completion and commercial release of the Company's GEMTM WIN and GEMS TM 4.0 software products removes any SLA penalty clauses which would have permitted MDP to acquire and use the unfinished GEMSTM software works without restriction and also ensures the Company retains the option to repurchase the SLA from MDP at any time for its original $500,000 value plus 10% interest compounded annually in cash or in units of CardioComm Solutions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EKG:CN C$0.09 CAD +0.02

EKG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $45.56 USD -0.75
LifeWatch AG SFr.12.00 CHF -0.65
View Industry Companies
 

Industry Analysis

EKG

Industry Average

Valuation EKG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOCOMM SOLUTIONS INC, please visit www.cardiocomm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.